BioSpace News Archive

OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to offer the best patient care, will host its latest State of the Science Summit™ on non-small cell lung cancer on Monday, June 17, from 5 to 9 p.m. at the Boston Marriott Newton in Newton, Massachusetts.

The cause of and cure for Alzheimer’s disease remain frustratingly elusive. In an effort to change that, the Infectious Diseases Society of America (IDSA) Foundation, with generous support from Alzheimer’s Germ Quest, Inc. and The Benter Foundation is offering five, one-time $100,000 grants to researchers seeking to identify a potential infectious link to the disease.

Wolf & Company P.C. is pleased to announce that Renee Broadbent has joined the firm, working with clients in the healthcare industry on improving their information security practices and compliance

A new post-hoc analysis of data from the EMPA-REG OUTCOME® trial indicates a consistent effect of Jardiance® (empagliflozin) on reducing cardiovascular and renal risk in adults with type 2 diabetes and known cardiovascular disease, who also have a form of chronic kidney disease without overt proteinuria (high levels of protein in the urine), as well as others in the trial

HealthChampion (www.myhealthchampion.com) -- the world’s first platform giving people unprecedented control over their healthcare information to improve their individual health goals and outcomes -- is now fully HIPAA compliant.

102% Growth in Mobile International Transfer Value Between 2019 & 2024

Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular drug manufacturer in China’s prescription drug market, announced that three abstracts regarding the clinical trial of the Group’s patented innovative drug Janagliflozin have been selected for poster presentation at the American Diabetes Association’s 79th Scientific Sessions.

Atlantis Healthcare announced the appointment of Neil Matheson as Non-Executive Chairman of the Board.

Sphere Fluidics announced that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment.

Deal valued at a total of USD 121M plus royalty payments